Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petr Kosztyu

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Journal of Cellular Physiology|April 27, 2011
P-glycoprotein mediates resistance to A3 adenosine receptor agonist 2-chloro-N6-(3-iodobenzyl)-adenosine-5'-n-methyluronamide in human leukemia cellsPetr Mlejnek, Petr Dolezel, Petr Kosztyu
Pharmacological Research|October 30, 2012
Can P-glycoprotein mediate resistance to nilotinib in human leukaemia cells?Petr Kosztyu, Petr Dolezel, Petr Mlejnek
European Journal of Haematology|October 18, 2014
Can the assessment of ABCB1 gene expression predict its function in vitro?Petr Kosztyu, Petr Dolezel, Radka Vaclavikova, et al.
Annals of Hematology|January 13, 2011
Interactions of N-desmethyl imatinib, an active metabolite of imatinib, with P-glycoprotein in human leukemia cellsPetr Mlejnek, Petr Dolezel, Edgar Faber, et al.
Chemico-Biological Interactions|June 24, 2014
Resistance to daunorubicin, imatinib, or nilotinib depends on expression levels of ABCB1 and ABCG2 in human leukemia cellsPetr Kosztyu, Romana Bukvova, Petr Dolezel, et al.
Chemico-Biological Interactions|June 18, 2017
Reversal of ABCB1 mediated efflux by imatinib and nilotinib in cells expressing various transporter levelsPetr Mlejnek, Petr Kosztyu, Petr Dolezel, et al.
Journal of Cellular Biochemistry|June 19, 2019
Estimation of ABCB1 concentration in plasma membranePetr Mlejnek, Petr Kosztyu, Petr Dolezel, et al.
Kidney International Reports|May 14, 2023
GalNAc-T14 may Contribute to Production of Galactose-Deficient Immunoglobulin A1, the Main Autoantigen in IgA NephropathyJana Jemelkova, Milada Stuchlova Horynova, Petr Kosztyu, et al.
Frontiers in Immunology|May 25, 2026
IgA nephropathy-associated breast milk B cell alterationsKaterina Zachova, Alica Cutkova, Petr Kosztyu, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|November 15, 2019
Multiparametric flow cytometry analysis of peripheral blood B cell trafficking differences among Epstein-Barr virus infected and uninfected subpopulationsKaterina Zachova, Petr Kosztyu, Josef Zadrazil, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Journal of Cellular Physiology|April 27, 2011
P-glycoprotein mediates resistance to A3 adenosine receptor agonist 2-chloro-N6-(3-iodobenzyl)-adenosine-5'-n-methyluronamide in human leukemia cellsPetr Mlejnek, Petr Dolezel, Petr Kosztyu
Pharmacological Research|October 30, 2012
Can P-glycoprotein mediate resistance to nilotinib in human leukaemia cells?Petr Kosztyu, Petr Dolezel, Petr Mlejnek
European Journal of Haematology|October 18, 2014
Can the assessment of ABCB1 gene expression predict its function in vitro?Petr Kosztyu, Petr Dolezel, Radka Vaclavikova, et al.
Annals of Hematology|January 13, 2011
Interactions of N-desmethyl imatinib, an active metabolite of imatinib, with P-glycoprotein in human leukemia cellsPetr Mlejnek, Petr Dolezel, Edgar Faber, et al.
Chemico-Biological Interactions|June 24, 2014
Resistance to daunorubicin, imatinib, or nilotinib depends on expression levels of ABCB1 and ABCG2 in human leukemia cellsPetr Kosztyu, Romana Bukvova, Petr Dolezel, et al.
Chemico-Biological Interactions|June 18, 2017
Reversal of ABCB1 mediated efflux by imatinib and nilotinib in cells expressing various transporter levelsPetr Mlejnek, Petr Kosztyu, Petr Dolezel, et al.
Journal of Cellular Biochemistry|June 19, 2019
Estimation of ABCB1 concentration in plasma membranePetr Mlejnek, Petr Kosztyu, Petr Dolezel, et al.
Kidney International Reports|May 14, 2023
GalNAc-T14 may Contribute to Production of Galactose-Deficient Immunoglobulin A1, the Main Autoantigen in IgA NephropathyJana Jemelkova, Milada Stuchlova Horynova, Petr Kosztyu, et al.
Frontiers in Immunology|May 25, 2026
IgA nephropathy-associated breast milk B cell alterationsKaterina Zachova, Alica Cutkova, Petr Kosztyu, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|November 15, 2019
Multiparametric flow cytometry analysis of peripheral blood B cell trafficking differences among Epstein-Barr virus infected and uninfected subpopulationsKaterina Zachova, Petr Kosztyu, Josef Zadrazil, et al.
Pageof 3